ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992

DCCR Receives 59 Community Hospital Oncology Program Proposals, Only here From Rural Areas

September 21, 1979

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

Brinker Again To Lead Komen As CEO

December 11, 2009